Infection with H. pylori is an up growing public health problem that affects approximately 50% of people in industrialized nations, and up to 80% in developing countries.
Introduction
Infection with H. pylori is a substantial public health problem that affects 20-50% of people in developed nations, and up to 80% in less developed countries 1 In ABH secretors, people secrete antigens according to their blood groups (for example, group O people will secrete H antigen, group A people will secrete A and H antigens, etc) 10 .
People who are ABH secretor probably have an ability to produce some biological decoys or metabolic chaff out into the gastric secretions that is very specific for H. pylori colonization. Also, in ABH non-secretors the immune response against H. pylori appears to be lower and H. pylori appears to attach with higher aggressiveness and cause more inflammation 11 .
In chronic H. pylori infection, could be implicated in the induction of auto reactive antibodies in the pathogenesis of H.
pylori-associated atrophic gastritis 12 . 32.33 .
Previous studies which showed that DUs were associated with blood group O, while GUs and gastric carcinoma were associated with blood group A 34, 35 . Strong association was found among Iraqi patients as wellattempt in this respect (though at a smaller scale), it may be (at least to our best knowledge); the first attempt to compare patients response to triple therapy in different blood groups or ABO phenotypes.
Materials and Methods

Study design
This is a prospective case control study performed on newly 
Patients
Inclusion criteria
• Patients aged between (15-77) years old.
• Patients with peptic ulcer disease (DU or GU)
achieved by endoscopy.
• Patients positive for H. pylori by two methods: the histological examination and stool antigen test or UBT performed in the specialized gastroenterology laboratory.
Exclusion criteria
• Patients with drug history over the past month which mimic those used in the present study.
• Patients who had received proton pump inhibitors, H 2 -blockers for a minimum of 2 weeks before test according to pervious study 37 .
• Patients who had received bismuth compounds in the past 4 weeks 37 .
• Patients who had severe concurrent disease that might affect the medical evaluation of this study.
• Pregnant and lactating Women.
• Patients who had severe gastroesophageal reflux disease (GERD), gastric tumors or history of gastrectomy.
• Patients with PUD who were smoker, NSAID users or alcoholics.
• Patients allergic to the study medications. 
Demographic data and disease characteristics:
Several studies demonstrated higher prevalence of H.
pylori positive than H. pylori negative in peptic ulcer and dyspeptic patients 43, 44, 45 . Furthermore, the probability of H. 49, 58, 59 . 
Distribution of H. pylori positive and negative in patients with peptic ulcer disease according to ABO phenotypes
The percentages of ABO phenotypes were analyzed in this study separately in accordance with H. pylori infection and non-infection (table 2). We observed that there was an association between H. pylori negative and blood group A, these finding was similar to that previously reported a higher 69, 70 . There is heterogeneity in the expression 
Distribution of gastric and duodenal ulcers according to ABO phenotypes
A higher incidence of GU (58.33%) in H. pylori positive was in blood group A when compared with other blood groups, while a higher incidence of DU (81.25%) in H. pylori positive was in blood group O when compared with other blood groups (Table 3) .
These findings agree with previous studies, which showed that DUs were associated with blood group O, while GUs and gastric carcinoma were associated with blood group A 74, 75, 76 .Furthermore, Syeda et al mentioned that the incidence of DU was 1.38 times in people belonging to blood group O as compared to other blood groups 77 .This may be explained that DU were associated with acid hypersecrtion, predominantly in patients with blood group O, while GU in the body of the stomach occurring in patients with normal duodenum,were characterized by acid hyposecretion and this marked in patients with blood group A, the cause that blood type A is most 5, 36 , including Iraqi population 36 . 77, 78 , and high gastric acidity was associated with reduced antibiotic therapy efficacy 82 , or potentially has antibiotic resistance compared with other blood groups 83 .
Conclusion
Association between H. pylori infection, ABO blood groups and Rh status in PUD has been widely evaluated over the past.
This study is another attempt in this respect (though at a smaller scale), it may be to the best knowledge the first attempt to compare patients response to H. pylori eradication triple therapy in different blood groups or ABO phenotypes, which showed lower eradication rate after H. pylori eradication coarse in infected peptic ulcer patients carrying blood group O phenotype compared to those holding other blood groups, with higher percentage of H. pylori-infection, and higher incidence of duodenal ulcer (DU).Further study is warranted to assess the response to other H. pylori eradication protocols in patients carrying blood group O phenotype in an attempt to improve the response rate.
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